Reference page — cumulative record through Monday, October 5, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Rt-claw
Product reference — Rt-claw by Zevorn · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 7 | 7 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 5.5 | .0050 | 0 | 0 | 6 | 1 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): █▁▁▁
| Month | New CVEs |
|---|---|
| 2026-07 | 7 |
| 2026-08 | 0 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-16204 | 2.1 | 43.9 | LOW | — | 2026-07-19 |
| CVE-2026-16201 | 5.5 | 43.0 | MEDIUM | — | 2026-07-19 |
| CVE-2026-16126 | 5.5 | 41.5 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16125 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16127 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16128 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16200 | 5.5 | 40.3 | MEDIUM | — | 2026-07-19 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-16204 | 2.1 | 43.9 | LOW | — | 2026-07-19 |
| CVE-2026-16201 | 5.5 | 43.0 | MEDIUM | — | 2026-07-19 |
| CVE-2026-16200 | 5.5 | 40.3 | MEDIUM | — | 2026-07-19 |
| CVE-2026-16128 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16127 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16126 | 5.5 | 41.5 | MEDIUM | — | 2026-07-18 |
| CVE-2026-16125 | 5.5 | 40.3 | MEDIUM | — | 2026-07-18 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Zevorn — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
